FDA expands tirzepatide indication to cardiovascular risk reduction

• by Kathryn Wighton

• August 28, 2026

2025 BP Guideline Could Reduce Mortality

Modeling of nationally representative US data suggested broader implementation of the AHA/ACC 's 2025 recommendations could expand antihypertensive treatment eligibility and reduce long-term mortality among high-risk adults.

• by Andrea Surnit

• July 29, 2026

• 4 min

AHA: Coffee Need Not Be Avoided in AF

Moderate coffee consumption generally appeared safe for most adults, but randomized evidence suggested divergent effects on atrial fibrillation and premature ventricular contractions.

• by Andrea Surnit

• July 20, 2026

• 5 min

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min